Radioembolization of yttrium-90 microspheres for hepatic malignancy

Seminars in Interventional Radiology

Volumn 25, Issue 1, 2008, Pages 48-57

  Murthy, Ravi ^a   Kamat, Parash ^a   Nunez, Rodolfo ^a   Salem, Riad ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Liver cancer; Radioembolization; Yttrium 90

Indexed keywords

EID: 42149087133     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1052306     Document Type: Article

References (37)

1. Gilbert HA, Kagan AR. Metastasis: incidence, detection and evaluation without histological confirmation. In: Weiss L, ed. Fundamental Aspects of Metastasis. Amsterdam: North Holland; 1976:385-405
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66
3. Fong Y, Cohen A, Fortner J, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15(3):938-946
4. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239(6):818-825
5. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139(10):817-823
6. Breedis C. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-77
7. Dawson LA, Normolle D, Baiter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002;53(4):810-821
8. Fox RA, Klemp PF, Egan G, Mina LL, Burton MA, Gray BN. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys 1991;21(2):463-467
9. Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004;60(5):1552-1563
10. Kennedy A, Salem R, Murthy R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 (Y90) microsphere brachytherapy: a Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Phys 2007;68(1):13-23
11. Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995;33(4):919-924
12. Nutting CKA, Coldwell D, Jones B, Quarnberg D. Coil embolization prevents GI ulcers during yttrium-90 hepatic radioembolization. J Vasc Interv Radiol 2004;15(suppl):2
13. Sarfaraz M, Kennedy A, Lodge M, Li X, Wu X, Yu C. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med Phys 2004;31(9):2449-2453
14. Sato K, Lewandowski RJ, Bui JT, et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 2006; 29(4):522-529
15. Murthy R, Xiong H, Nunez R, et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 2005; 16(7):937-945
16. Marn CS, Andrews JC, Francis IR, Hollett MD, Walker SC, Ensminger WD. Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings. Radiology 1993;187(1): 125-128
17. Wong CY, Salem R, Raman S, Gates VL, Dworkin HJ. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med MoI Imaging 2002;29(6):815-820
18. Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum 1979;22(6):371-375
19. Mantravadi RV, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 1982;142(3):783-786
20. Gray BN, Burton MA, Kelleher DK, Anderson J, Klemp P. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol 1989;42(3):192-196
21. Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust NZJ Surg 1992;62(2):105-110
22. Gray B, Van Hazel G, Buck M, Paton G, Burton M, Anderson J. Treatment of colorectal liver metastases with SIR-Spheres plus chemotherapy. GI Cancer 2000;3(4):249-257
23. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12(12):1711-1720
24. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001;5(3): 294-302
25. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88(2): 78-85
26. Sharma RA, Van Hazel GA, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25(9):1099-1106
27. Van Hazel G. Selective internal radiation therapy (SIRT) plus systemic chemotherapy with Irinotecan: a phase I dose escalation study. ASCO GI Symposium; 2005
28. Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006;65(2):412-425
29. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 1994; 70(5):994-999
30. Lau WY, Ho S, Leung T, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998;40(3):583-592
31. Dancey JE, Shepherd FA, Paul K, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 2000;41(10):1673-1681
32. Carr BI. Hepatic arterial 90Yttrium glass microspheres (TheraSphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004;10(suppl 1):S107-S110
33. Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S194-S205
34. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005;16:205-213
35. Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 2004;240:299-305
36. Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS. Successful embolization of hepatocellular carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg 2006;10:413-416
37. Thamboo T, Tan KB, Wang SC, Salto-Tellez M. Extrahepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver. Pathology 2003;35(4):351-353